Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
33
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      The Clinical Opiate Withdrawal Scale (COWS)

      1 , 2
      Journal of Psychoactive Drugs
      Informa UK Limited

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The clinical opiate withdrawal scale (COWS) is a clinician-administered, pen and paper instrument that rates eleven common opiate withdrawal signs or symptoms. The summed score of the eleven items can be used to assess a patient's level of opiate withdrawal and to make inferences about their level of physical dependence on opioids. With increasing use of opioids for treatment of pain and the availability of sublingual buprenorphine in the United States for treatment of opioid dependence, clinical assessment of opiate withdrawal intensity has received renewed interest. Buprenorphine, a partial opiate agonist at the mu receptor, can precipitate opiate withdrawal in patients with a high level of opioid dependence who are not experiencing opioid withdrawal. Since development of the first opiate withdrawal scale in the mid-1930s, many different opioid withdrawal scales have been used in clinical and research settings. This article reviews the history of opiate withdrawal scales and the context of their initial use. A template version of the COWS that can be copied and used clinically is appended. PDF formatted versions of the COWS are also available from the websites of the American Society of Addiction Medicine, the California Society of Addiction Medicine, the UCLA Integrated Substance Abuse Programs, and AlcoholMD.com.

          Related collections

          Author and article information

          Journal
          Journal of Psychoactive Drugs
          Journal of Psychoactive Drugs
          Informa UK Limited
          0279-1072
          2159-9777
          June 01 2003
          September 07 2011
          June 01 2003
          : 35
          : 2
          : 253-259
          Affiliations
          [1 ] a CNS Medications Development , Oakland, California
          [2 ] b Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences , David Geffen School of Medicine at University of California Los Angeles
          Article
          10.1080/02791072.2003.10400007
          12924748
          fdc79a82-5a2e-47f0-bf18-278bb4b44983
          © 2003
          History

          Comments

          Comment on this article